Corcept Therapeutics Inc
CORT· Nasdaq
Released May 4, 2020, after the close
10-Q filed May 4, 2020, 34 days after period end · 0001628280-20-006270
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Revenue | $93.25M | $64.83M | $57.66M | $27.60M |
| Net Income | $30.07M | $18.27M | $17.46M | $4.39M |
| EPS Diluted |
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR
| $0.25 |
| $0.15 |
| $0.14 |
| $0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.